Najit Technologies, Inc.
πΊπΈUnited States
- Country
- πΊπΈUnited States
- Ownership
- Private
- Established
- 2004-01-01
- Employees
- 1
- Market Cap
- -
- Website
- https://www.najittech.com
Clinical Trials
2
Active:1
Completed:1
Trial Phases
1 Phases
Phase 1:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)β’ Click on a phase to view related trials
Phase 1
2 (100.0%)Trial of an Inactivated Chikungunya Virus Vaccine
Phase 1
Active, not recruiting
- Conditions
- Chikungunya FeverChikungunya VirusChikungunya
- Interventions
- Other: Placebo
- First Posted Date
- 2024-11-01
- Last Posted Date
- 2025-10-07
- Lead Sponsor
- Najit Technologies, Inc.
- Target Recruit Count
- 48
- Registration Number
- NCT06669208
- Locations
- πΊπΈ
Duke University Health System, Durham, North Carolina, United States
Trial of an Inactivated Yellow Fever Virus Vaccine
- First Posted Date
- 2021-12-29
- Last Posted Date
- 2025-09-18
- Lead Sponsor
- Najit Technologies, Inc.
- Target Recruit Count
- 26
- Registration Number
- NCT05172544
- Locations
- πΊπΈ
Duke University Health System, Durham, North Carolina, United States
News
No news found